Gene · 1613
Papers1,713
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 1,713
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyanide Poisoning Compromises Gene Pathways Modulating Cardiac Injury in Vivo. | Chem Res Toxicol | 2021 | 33914522 | PubTator, text mining | PubMed |
| Controlling for cellular heterogeneity using single-cell deconvolution of gene expression reveals novel markers of colorectal tumors exhibiting microsatellite instability. | Oncotarget | 2021 | 33889300 | PubTator, text mining | PubMed |
| The role of cation diffusion facilitator CDF-1 in lipid metabolism in Caenorhabditis elegans. | G3 (Bethesda) | 2021 | 33871589 | PubTator, text mining | PubMed |
| Update on the Mechanisms of Tubular Cell Injury in Diabetic Kidney Disease. | Front Med (Lausanne) | 2021 | 33859992 | PubTator, text mining | PubMed |
| Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer. | Nat Commun | 2021 | 33846331 | PubTator, text mining | PubMed |
| Recommending encounters according to the sociodemographic characteristics of patient strata can reduce risks from type 2 diabetes. | PLoS One | 2021 | 33844693 | PubTator, text mining | PubMed |
| From Photoinduced Supramolecular Polymerization to Responsive Organogels. | J Am Chem Soc | 2021 | 33830767 | PubTator, text mining | PubMed |
| Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study. | Molecules | 2021 | 33807474 | PubTator, text mining | PubMed |
| Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells. | Cancers (Basel) | 2021 | 33806450 | PubTator, text mining | PubMed |
| Copper Toxicity Is Not Just Oxidative Damage: Zinc Systems and Insight from Wilson Disease. | Biomedicines | 2021 | 33804693 | PubTator, text mining | PubMed |
| ZIP8 exacerbates collagen-induced arthritis by increasing pathogenic T cell responses. | Exp Mol Med | 2021 | 33795795 | PubTator, text mining | PubMed |
| TFEB regulates pluripotency transcriptional network in mouse embryonic stem cells independent of autophagy-lysosomal biogenesis. | Cell Death Dis | 2021 | 33795648 | PubTator, text mining | PubMed |
| Brain Magnetic Resonance Imaging Phenome-Wide Association Study With Metal Transporter Gene SLC39A8. | Front Genet | 2021 | 33790950 | PubTator, text mining | PubMed |
| Rapamycin Inhibits Glioma Cells Growth and Promotes Autophagy by miR-26a-5p/DAPK1 Axis. | Cancer Manag Res | 2021 | 33790644 | PubTator, text mining | PubMed |
| An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress. | Cancer Cell Int | 2021 | 33789681 | PubTator, text mining | PubMed |
| PIM2-mediated phosphorylation contributes to granulosa cell survival via resisting apoptosis during folliculogenesis. | Clin Transl Med | 2021 | 33783992 | PubTator, text mining | PubMed |
| The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-β pathway. | Nat Immunol | 2021 | 33767426 | PubTator, text mining | PubMed |
| Luteal Phase Ovarian Stimulation versus Follicular Phase Ovarian Stimulation results in different Human Cumulus cell genes expression: A pilot study. | Int J Med Sci | 2021 | 33746576 | PubTator, text mining | PubMed |
| Fluorescence-detection size-exclusion chromatography utilizing nanobody technology for expression screening of membrane proteins. | Commun Biol | 2021 | 33742097 | PubTator, text mining | PubMed |
| Knockdown of SLC39A4 Expression Inhibits the Proliferation and Motility of Gallbladder Cancer Cells and Tumor Formation in Nude Mice. | Cancer Manag Res | 2021 | 33727860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1613/papers?page=28